- Home
- NVAX vs XPRO Comparison
NVAX vs XPRO Comparison
Compare NVAX & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- XPRO
- Stock Information
- Founded
- NVAX 1987
- XPRO 1938
- Country
- NVAX United States
- XPRO United States
- Employees
- NVAX N/A
- XPRO N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- XPRO Oilfield Services/Equipment
- Sector
- NVAX Health Care
- XPRO Energy
- Exchange
- NVAX Nasdaq
- XPRO Nasdaq
- Market Cap
- NVAX 1.3B
- XPRO 935.2M
- IPO Year
- NVAX 1995
- XPRO 2013
- Fundamental
- Price
- NVAX $6.66
- XPRO $8.27
- Analyst Decision
- NVAX Buy
- XPRO Buy
- Analyst Count
- NVAX 6
- XPRO 3
- Target Price
- NVAX $17.83
- XPRO $17.67
- AVG Volume (30 Days)
- NVAX 8.5M
- XPRO 1.3M
- Earning Date
- NVAX 05-08-2025
- XPRO 04-30-2025
- Dividend Yield
- NVAX N/A
- XPRO N/A
- EPS Growth
- NVAX N/A
- XPRO N/A
- EPS
- NVAX 2.97
- XPRO 0.58
- Revenue
- NVAX $1,254,962,000.00
- XPRO $1,720,185,000.00
- Revenue This Year
- NVAX N/A
- XPRO $1.06
- Revenue Next Year
- NVAX N/A
- XPRO $4.33
- P/E Ratio
- NVAX $2.24
- XPRO $14.18
- Revenue Growth
- NVAX 25.92
- XPRO 10.48
- 52 Week Low
- NVAX $4.43
- XPRO $6.70
- 52 Week High
- NVAX $23.86
- XPRO $24.50
- Technical
- Relative Strength Index (RSI)
- NVAX 51.25
- XPRO 41.62
- Support Level
- NVAX $5.82
- XPRO $7.60
- Resistance Level
- NVAX $6.61
- XPRO $8.63
- Average True Range (ATR)
- NVAX 0.53
- XPRO 0.49
- MACD
- NVAX 0.02
- XPRO 0.07
- Stochastic Oscillator
- NVAX 42.21
- XPRO 21.60
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.